1. Antiviral Activity of PLK1-Targeting siRNA Delivered by Lipid Nanoparticles in HBV-Infected Hepatocytes. Issue 3 (April 2020) Authors: Foca, Adrien; Dhillon, Ammen; Lahlali, Thomas; Lucifora, Julie; Salvetti, Anna; Rivoire, Michel; Lee, Amy; Durantel, David Journal: Antiviral therapy Issue: Volume 25:Issue 3(2020) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Polo‐like‐kinase 1 is a proviral host factor for hepatitis B virus replication. Issue 6 (6th November 2017) Authors: Diab, Ahmed; Foca, Adrien; Fusil, Floriane; Lahlali, Thomas; Jalaguier, Pascal; Amirache, Fouzia; N'Guyen, Lia; Isorce, Nathalie; Cosset, François‐Loïc; Zoulim, Fabien; Andrisani, Ourania; Durantel, David Journal: Hepatology Issue: Volume 66:Issue 6(2017) Page Start: 1750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatments for COVID-19: Lessons from 2020 and new therapeutic options. (February 2022) Authors: Salasc, Fanny; Lahlali, Thomas; Laurent, Emilie; Rosa-Calatrava, Manuel; Pizzorno, Andrés Journal: Current opinion in pharmacology Issue: Volume 62(2022) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗